New York AG asks FDA to double down on warnings, discourage prescription for asthma drug

The New York attorney general’s office is asking the Food and Drug Administration (FDA) to double down on its warnings and discourage the use of an asthma drug. “The New York Office of the Attorney General writes to encourage the FDA to address the dangers of montelukast, particularly to the most vulnerable population—minor children—and protect… Source

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes